Allergan's CEO Pay Plummets by 80%

Source: FiercePharma

Wednesday, March 29, 2017 | Earnings & Financials , Allergan


After a 2016 that hit some bumps financially—and one that didn’t feature the Pfizer-Allergan merger the companies had planned on—Allergan CEO Brent Saunders’ pay is down. Way, way down. The Dublin drugmaker’s chief exec pocketed just $4.1 million in 2016, a sum that’s less than one-fifth of the $21.6 million he took home in 2015—and just 11.3% of his 2014 haul.

Included in last year’s figure were a base salary of $1.0 million, along with $2.9 million in nonequity incentive plan compensation, a $2,035 change in pension value, and $173,568 in other freebies, including aircraft use and a car and driver allowance.

After a 2016 that hit some bumps financially—and one that didn’t feature the Pfizer-Allergan merger the companies had planned on—Allergan CEO Brent Saunders’ pay is down. Way, way down.

The Dublin drugmaker’s chief exec pocketed just $4.1 million in 2016, a sum that’s less than one-fifth of the $21.6 million he took home in 2015—and just 11.3% of his 2014 haul. Included in last year’s figure were a base salary of $1.0 million, along with $2.9 million in nonequity incentive plan compensation, a $2,035 change in pension value, and $173,568 in other freebies, including aircraft use and a car and driver allowance.

To read the full article from FiercePharma, visit http://www.fiercepharma.com/pharma/allergan-s-ceo-pay-plummets-by-80-without-big-m-a-and-strong-financials.

Open in New Window

Comments

You must be logged in to leave a comment.